Johnson & Johnson (JNJ) call put ratio 1.6 calls to 1 put into quarter results Oct 8, 2026 05:37AM
Guggenheim Reiterates Buy Rating on Johnson & Johnson (JNJ) Oct 7, 2026 07:30AM
Johnson & Johnson (JNJ) PT Raised to $290 at RBC Capital Oct 6, 2026 05:59AM
J&J releases 2-year icotrokinra data for hard-to-treat plaque psoriasis Oct 2, 2026 06:03AM
J&J presents two-year IMAAVY data in adolescent myasthenia gravis Sep 29, 2026 08:05AM
View Older Stories

Sep 29, 2026 05:28AM Johnson & Johnson (JNJ) PT Raised to $278 at BofA Securities
Sep 22, 2026 09:29AM UBS Reiterates Buy Rating on Johnson & Johnson (JNJ)
Sep 15, 2026 06:04AM J&J lung cancer drug combo shows low side effect rates in study
Sep 14, 2026 04:30AM Johnson & Johnson lung cancer drug shows 34-month survival in phase 3 trial
Sep 10, 2026 07:46AM Johnson & Johnson gets CE mark for Acuvue Oasys MAX 2-Week lens
Sep 8, 2026 08:02AM Johnson & Johnson to present neuropsychiatry data at Psych Congress 2026
Aug 26, 2026 02:00PM FDA: issues early alert on Abiomed heart pump controller purge cassette issue
Aug 18, 2026 07:40AM Piper Sandler: PFA survey is most positive for Medtronic, Inc. (MDT)
Aug 12, 2026 08:32AM Intuitive Surgical: Oppenheimer now bullish, sees competition being "crowded out"
Aug 7, 2026 12:04PM Morgan Stanley tracks US drug market prescriptions for week ending July 31
Aug 6, 2026 07:39AM Johnson & Johnson (JNJ) PT Raised to $287 at Guggenheim
Aug 3, 2026 02:37PM Johnson & Johnson (JNJ) PT Raised to $280 at Raymond James
Aug 3, 2026 08:01AM Microsoft joins, Broadcom exits Goldman's top-stocks list
Aug 3, 2026 05:42AM Goldman Monthly Update to US Director's Cut List
Jul 28, 2026 06:04AM Johnson & Johnson (JNJ) call put ratio 1 call to 1 put unto J&J to settle ovarian talc claims
Jul 28, 2026 03:08AM Johnson & Johnson agrees to $5.5B settlement of ovarian talc claims
Jul 22, 2026 07:01AM FDA clears Johnson & Johnson's Ottava robotic surgical system
Jul 16, 2026 01:27PM Freedom Capital Upgrades Johnson & Johnson (JNJ) to Buy
Jul 16, 2026 08:49AM Johnson & Johnson (JNJ) PT Raised to $261 at Bernstein SocGen
Jul 16, 2026 06:40AM Guggenheim Reiterates Buy Rating on Johnson & Johnson (JNJ)
Jul 15, 2026 06:21AM Johnson & Johnson (JNJ) Tops Q2 EPS by 4c; raises guidance
Jul 15, 2026 03:00AM Johnson & Johnson Q2 earnings preview: analysts eye product launch progress
Jul 14, 2026 11:28AM Johnson & Johnson (JNJ) call put ratio 1.6 calls to 1 put into quarter results
Jul 14, 2026 06:41AM Johnson & Johnson (JNJ) call put ratio 1.5 calls to 1 put into quarter results
Jul 13, 2026 11:09AM Johnson & Johnson (JNJ) call put ratio 2.8 calls to 1 put into quarter results
Jul 7, 2026 10:31AM Increasing unusual put volume: AEVA SOLS LI TAP MTUM VSAT CMPS FPS CBRL JNJ NTAP
Jul 2, 2026 10:29AM Increasing unusual put volume: XLI EQT ARKG ROST WEN KOS BKLN UUP DB DJ JNJ LOW FVRR
Jun 29, 2026 04:33PM DePuy Synthes names Christina Zamarro as CFO, effective July 2026
Jun 26, 2026 12:35PM J&J presents new IMAAVY data for myasthenia gravis at EAN 2026
Jun 26, 2026 08:16AM Johnson & Johnson (JNJ) PT Raised to $270 at Guggenheim
Jun 17, 2026 11:15AM Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says
Jun 15, 2026 06:01AM Johnson & Johnson invests $1 billion in Jacksonville vision manufacturing
Jun 14, 2026 02:01PM Johnson & Johnson shows positive results for TALVEY-DARZALEX drug combination
Jun 12, 2026 02:42PM Leerink highlights drug demand rebound after Memorial Day
Jun 11, 2026 07:45AM Johnson & Johnson expands US availability of TECNIS PureSee IOL
Jun 11, 2026 07:43AM Johnson & Johnson reports positive results for rare blood disorder treatment
Jun 10, 2026 11:22AM Johnson & Johnson faces $32 million verdict in Los Angeles asbestos case
Jun 3, 2026 03:14AM Johnson & Johnson reports nipocalimab shows stronger response in Sjögren's patients
May 29, 2026 02:00PM J&J's RYBREVANT plus LAZCLUZE shows 3.5-year survival in lung cancer study
May 29, 2026 08:41AM Johnson & Johnson TECVAYLI shows survival benefits in myeloma study
May 26, 2026 08:03AM DePuy Synthes signs exclusive distribution deal with CGBIO for bone graft
May 15, 2026 02:58PM FDA approves accord Biopharma's Immgolis, a biosimilar to Simponi
May 14, 2026 04:01PM Johnson & Johnson survey finds bladder cancer treatments impact patient quality of life
May 13, 2026 06:10AM Leerink Partners Upgrades Johnson & Johnson (JNJ) to Outperform
May 12, 2026 07:45AM Johnson & Johnson launches Shockwave C2 Aero coronary catheter globally
May 11, 2026 08:01AM Johnson & Johnson presents neuropsychiatry data at medical conferences
May 6, 2026 04:28AM Protagonist Therapeutics (PTGX) PT Raised to $137 at Citizens
May 5, 2026 08:05AM Johnson & Johnson's TREMFYA shows efficacy in perianal fistulizing Crohn's
May 5, 2026 08:05AM Johnson & Johnson reports positive phase 2b results for experimental IBD therapy
May 5, 2026 07:00AM Johnson & Johnson reports clinical trial results for robotic surgery system
View Older Stories